Pr Giselle Saulnier Sholler is currently Director of Pediatric Oncology Research, and Head of the Pediatric Oncology Translational Research Laboratory in the Helen DeVos Children’s Hospital, in Grand Rapids, MI, USA.
She is also an Associate Professor of the Michigan State University College of Human Medicine and Chair of the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC)
After completing her Residency and Pediatric Hematology/Oncology Fellowship at Brown University, Providence and Hasbro Children’s Hospital/Rhode Island Hospital, Pr Sholler became assistant Professor of Pediatrics, Division of Pediatric Hematology/Oncology University of Vermont, Burlington VT and worked as a Guest Researcher in Pediatric Oncology Branch of the NCI, NIH in Bethesda, MD. She then joined the Van Andel Research Institute and the University of Vermont.
Pr Sholler is the author of 20 publications and is currently working on a Trial using Molecular-Guided Therapy for the Treatment of Patients with Refractory or Recurrent tumour within the NMTCR.
She is the member of several associations including the AACR, ASCO, COG and SIOP20